Canopy Growth (CGC) Operating Margin Growth (3y) (2022 - 2025)
Canopy Growth (CGC) Operating Margin Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -1,442.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 5,193.00 |
| 10 | Canopy Growth | 276.52 Mn | 10.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,194.00 |
| Sep 30, 2025 | 14,429.00 |
| Jun 30, 2025 | 152,124.00 |
| Dec 31, 2024 | 6,487.00 |
| Sep 30, 2024 | 9,099.00 |
| Jun 30, 2024 | 9,385.00 |
| Mar 31, 2024 | 1,046.00 |
| Dec 31, 2023 | 310,870.00 |
| Sep 30, 2023 | 20,008.00 |
| Jun 30, 2023 | 7,308.00 |
| Mar 31, 2023 | 44,966.00 |
| Dec 31, 2022 | 2,263.00 |
| Sep 30, 2022 | 18,389.00 |
| Jun 30, 2022 | -131,529.00 |
| Mar 31, 2022 | 11,198.00 |